Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues.

The aim of this study was to engineer a biomaterial capable of supporting vascularization in vitro and in vivo. We covalently immobilized vascular endothelial growth factor (VEGF) and Angiopoietin-1 (Ang1) onto three-dimensional porous collagen scaffolds using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) chemistry. Over both 3 and 7 days in vitro, seeded endothelial cells (ECs) had increased proliferation on scaffolds with immobilized VEGF and/or Ang1 compared to unmodified scaffolds and soluble growth factor controls. Notably, the group with co-immobilized VEGF and Ang1 showed significantly higher cell number (P=0.0079), higher overall lactate production rate (P=0.0044) and higher overall glucose consumption rate (P=0.0034) at Day 3, compared to its corresponding soluble control for which growth factors were added to culture medium. By Day 7, hematoxylin and eosin, live/dead, CD31, and von Willebrand factor staining all showed improved tube formation by ECs when cultivated on scaffolds with co-immobilized growth factors. Interestingly, scaffolds with co-immobilized VEGF and Ang1 showed increased EC infiltration in the chorioallantoic membrane (CAM) assay, compared to scaffolds with independently immobilized VEGF/Ang1. This study presents an alternative method for promoting the formation of vascular structures, via covalent immobilization of angiogenic growth factors that are more stable than soluble ones and have a localized effect.

[1]  Masanori Fujita,et al.  Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. , 2004, Biomaterials.

[2]  G. Prestwich,et al.  Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. , 2008, Biomaterials.

[3]  S. Eccles,et al.  Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  E. Dejana,et al.  Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[5]  X. Gao,et al.  VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways , 2005, Gene Therapy.

[6]  V. V. van Hinsbergh,et al.  Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. , 2000, Blood.

[7]  Xiao-pei Gao,et al.  Angiopoietin-1 Opposes VEGF-Induced Increase in Endothelial Permeability by Inhibiting TRPC1-Dependent Ca2+ Influx , 2005, Circulation research.

[8]  B. Christ,et al.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane , 1993, Cell and Tissue Research.

[9]  Sung Hyun Kim,et al.  COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Elvassore,et al.  Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. , 2007, Biomaterials.

[11]  Fen Chen,et al.  Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. , 2006, Tissue engineering.

[12]  Blanca E Himes,et al.  Angiopoietin-1 Promotes Cardiac and Skeletal Myocyte Survival Through Integrins , 2005, Circulation research.

[13]  David J Mooney,et al.  Protein-based signaling systems in tissue engineering. , 2003, Current opinion in biotechnology.

[14]  Hyoungshin Park,et al.  Effects of regulatory factors on engineered cardiac tissue in vitro. , 2007, Tissue engineering.

[15]  J. Hunt,et al.  The angiogenic potential of three-dimensional open porous synthetic matrix materials. , 2007, Biomaterials.

[16]  Shelly R. Peyton,et al.  The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. , 2006, Biomaterials.

[17]  Aleksander S. Popel,et al.  A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap , 2009, PloS one.

[18]  David J Mooney,et al.  Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.

[19]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[20]  C. Leclerc,et al.  Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines. , 2008, Journal of biomedical materials research. Part A.

[21]  C. Garlanda,et al.  Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice , 2004, Angiogenesis.

[22]  W. Thompson,et al.  Angiogenesis assays using chick chorioallantoic membrane. , 2001, Methods in molecular medicine.

[23]  Kazuo Tanishita,et al.  Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells. , 2007, Tissue engineering.

[24]  C. Garlanda,et al.  Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[26]  R. Nicosia,et al.  Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. , 2002, The American journal of pathology.

[27]  Shouren Ge,et al.  Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. , 2007, Biomaterials.

[28]  Silviu Itescu,et al.  Cardiac Tissue Engineering in an In Vivo Vascularized Chamber , 2007, Circulation.

[29]  Chun-yan Zhou,et al.  Angiopoietin-1 protects H9c2 cells from H2O2-induced apoptosis through AKT signaling. , 2007, Biochemical and biophysical research communications.

[30]  Dai Fukumura,et al.  Engineering vascularized tissue , 2005, Nature Biotechnology.

[31]  D. Dumont,et al.  Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization , 2006, Journal of Cell Science.

[32]  M. Radisic,et al.  Pulsatile perfusion bioreactor for cardiac tissue engineering , 2008, Biotechnology progress.

[33]  Yoshihiro Ito,et al.  Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.

[34]  L. Zentilin,et al.  Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  J. Gutkind,et al.  Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. , 2008, Developmental cell.

[36]  G. Dusting,et al.  Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase , 2008, Journal of cellular and molecular medicine.

[37]  Hyun Jung Chung,et al.  Perspectives On: Local and Sustained Delivery of Angiogenic Growth Factors , 2007 .

[38]  G. Prestwich,et al.  Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. , 2006, Biomaterials.

[39]  Yihai Cao,et al.  Embryonic Stem Cell-Derived Embryoid Bodies Development in Collagen Gels Recapitulates Sprouting Angiogenesis , 2001, Laboratory Investigation.

[40]  Guoping Chen,et al.  Cellular control of tissue architectures using a three-dimensional tissue fabrication technique. , 2007, Biomaterials.

[41]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[42]  Milica Radisic,et al.  Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. , 2011, Tissue engineering. Part A.

[43]  Claudia Fischbach,et al.  Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis , 2005, Laboratory Investigation.

[44]  Robert Langer,et al.  Endothelialized microvasculature based on a biodegradable elastomer. , 2005, Tissue engineering.

[45]  M. von Walter,et al.  Biomimetic modification of the TiO(2)/glass composite Ecopore with heparinized collagen and the osteoinductive factor BMP-2. , 2008, Acta biomaterialia.

[46]  N Pallua,et al.  Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. , 2004, Tissue engineering.

[47]  S. Simpson.  Of Mice . . . , 2004, Science.

[48]  Takashi Urano,et al.  Angiopoietins and angiopoietin-like proteins in angiogenesis. , 2006, Endothelium : journal of endothelial cell research.

[49]  Y. Wang,et al.  Cell locomotion and focal adhesions are regulated by substrate flexibility. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Hallahan,et al.  Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. , 2004, Experimental cell research.

[51]  K Rakusan,et al.  The effect of growth and aging on functional capillary supply of the rat heart. , 1982, Growth.

[52]  G. Koh,et al.  Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. , 2000, Circulation.

[53]  Milica Radisic,et al.  Optical mapping of impulse propagation in engineered cardiac tissue. , 2009, Tissue engineering. Part A.

[54]  Milica Radisic,et al.  Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue , 2006, Biotechnology and bioengineering.

[55]  J. Gergely,et al.  Zero-length crosslinking procedure with the use of active esters. , 1990, Analytical biochemistry.

[56]  Lena Claesson-Welsh,et al.  VEGF Receptor Signal Transduction , 2001, Science's STKE.

[57]  F. Bussolino,et al.  Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1 , 2005, The Journal of cell biology.

[58]  M. Giacca,et al.  In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature. , 2007, Human gene therapy.

[59]  M. Shibuya,et al.  Induction of tube formation by angiopoietin‐1 in endothelial cell/fibroblast co‐culture is dependent on endogenous VEGF , 2003, Cancer science.

[60]  Sung Hye Kim,et al.  Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors , 2007, Peptides.

[61]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[62]  Feng-Huei Lin,et al.  Release characteristics and bioactivity of gelatin-tricalcium phosphate membranes covalently immobilized with nerve growth factors. , 2005, Biomaterials.

[63]  M. Kutryk,et al.  Angiogenesis of the heart , 2003, Microscopy research and technique.

[64]  Milica Radisic,et al.  Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. , 2008, Acta biomaterialia.

[65]  K. Shyu,et al.  Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction , 2005, European journal of clinical investigation.

[66]  Y Ikada,et al.  Controlled release of vascular endothelial growth factor by use of collagen hydrogels , 2000, Journal of biomaterials science. Polymer edition.

[67]  S. Tian,et al.  Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF. , 2004, Microvascular research.

[68]  Milica Radisic,et al.  Medium perfusion enables engineering of compact and contractile cardiac tissue. , 2004, American journal of physiology. Heart and circulatory physiology.

[69]  H. Blau,et al.  VEGF gene delivery to myocardium: deleterious effects of unregulated expression. , 2000, Circulation.

[70]  S. Harper,et al.  VEGF and Angiopoietin‐1 Stimulate Different Angiogenic Phenotypes That Combine to Enhance Functional Neovascularization in Adult Tissue , 2006, Microcirculation.

[71]  Milica Radisic,et al.  A novel composite scaffold for cardiac tissue engineering , 2005, In Vitro Cellular & Developmental Biology - Animal.